Jill M Spoerke

Jill M Spoerke

UNVERIFIED PROFILE

Are you Jill M Spoerke?   Register this Author

Register author
Jill M Spoerke

Jill M Spoerke

Publications by authors named "Jill M Spoerke"

Are you Jill M Spoerke?   Register this Author

22Publications

928Reads

11Profile Views

Genomic Alterations Associated with Recurrence and TNBC Subtype in High-Risk Early Breast Cancers.

Mol Cancer Res 2019 01 31;17(1):97-108. Epub 2018 Aug 31.

Department of Oncology Biomarker Development, Genentech, Inc., South San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-18-0619DOI Listing
January 2019

Randomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma.

J Clin Oncol 2016 05 7;34(14):1660-8. Epub 2016 Mar 7.

Thomas Powles, Queen Mary University of London, London; Christy Ralph, University of Leeds, Leeds; Janet E. Brown, University of Sheffield, Sheffield; Robert E. Hawkins, University of Manchester, Manchester, United Kingdom; Mark R. Lackner, Wei Lin, Bridget O'Keeffe, Yulei Wang, Shan Lu, Jill M. Spoerke, Ling Yuh Huw, Michelle Byrtek, Rui Zhu, and Joseph A. Ware, Genentech, South San Francisco, CA; Robert J. Motzer, Memorial Sloan Kettering Cancer Center, New York, NY; Brian I. Rini, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Bernard Escudier, Institut Gustave Roussy, Villejuif; Alain Ravaud, Hospital Saint Andre, Bordeaux; Stéphane Oudard, University Paris Descartes, Paris, France; Daniel Castellano, University Hospital 12 de Octubre, Madrid, Spain; and Michael D. Staehler, University Hospital Munich-Grosshadern, Marchioninistrasse, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.8808DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569691PMC
May 2016

Activating Mutations in PIK3CB Confer Resistance to PI3K Inhibition and Define a Novel Oncogenic Role for p110β.

Cancer Res 2016 Mar 12;76(5):1193-203. Epub 2016 Jan 12.

Department of Oncology Biomarker Development, Genentech, Inc., South San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-15-2201DOI Listing
March 2016

Molecular biomarker analyses using circulating tumor cells.

PLoS One 2010 Sep 8;5(9):e12517. Epub 2010 Sep 8.

Department of Oncology Biomarker Development, Genentech, Inc, South San Francisco, California, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012517PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935889PMC
September 2010

DIVERGENCE IN SYMBIOTIC COMPATIBILITY IN A LEGUME-BRADYRHIZOBIUM MUTUALISM.

Evolution 1996 Aug;50(4):1470-1477

Department of Biological Sciences, State University of New York, Binghamton, New York, 13902-6000.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1558-5646.1996.tb03920.xDOI Listing
August 1996

NONRANDOM GENOTYPIC ASSOCIATIONS IN A LEGUME-BRADYRHIZOBIUM MUTUALISM.

Evolution 1996 Feb;50(1):146-154

Department of Biological Sciences, State University of New York, Binghamton, New York, 13902-6000.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1558-5646.1996.tb04481.xDOI Listing
February 1996